232 related articles for article (PubMed ID: 33288739)
21. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
22. The role of Mg2+ cofactor in the guanine nucleotide exchange and GTP hydrolysis reactions of Rho family GTP-binding proteins.
Zhang B; Zhang Y; Wang Z; Zheng Y
J Biol Chem; 2000 Aug; 275(33):25299-307. PubMed ID: 10843989
[TBL] [Abstract][Full Text] [Related]
23. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
24. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
25. The human orthologue of CdGAP is a phosphoprotein and a GTPase-activating protein for Cdc42 and Rac1 but not RhoA.
Tcherkezian J; Triki I; Stenne R; Danek EI; Lamarche-Vane N
Biol Cell; 2006 Aug; 98(8):445-56. PubMed ID: 16519628
[TBL] [Abstract][Full Text] [Related]
26. Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cells.
Miyamoto S; Nagamura Y; Nakabo A; Okabe A; Yanagihara K; Fukami K; Sakai R; Yamaguchi H
Biochem Biophys Res Commun; 2018 Jan; 495(2):1942-1947. PubMed ID: 29247652
[TBL] [Abstract][Full Text] [Related]
27. Vav2 is an activator of Cdc42, Rac1, and RhoA.
Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
[TBL] [Abstract][Full Text] [Related]
28. G alpha 13 signals via p115RhoGEF cascades regulating JNK1 and primitive endoderm formation.
Lee YN; Malbon CC; Wang HY
J Biol Chem; 2004 Dec; 279(52):54896-904. PubMed ID: 15492006
[TBL] [Abstract][Full Text] [Related]
29. Activation of type I phosphatidylinositol 4-phosphate 5-kinase isoforms by the Rho GTPases, RhoA, Rac1, and Cdc42.
Weernink PA; Meletiadis K; Hommeltenberg S; Hinz M; Ishihara H; Schmidt M; Jakobs KH
J Biol Chem; 2004 Feb; 279(9):7840-9. PubMed ID: 14681219
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
31. In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model.
Nishizawa T; Nakano K; Fujii E; Komura D; Kuroiwa Y; Ishimaru C; Monnai M; Aburatani H; Ishikawa S; Suzuki M
Oncol Rep; 2019 Nov; 42(5):1745-1754. PubMed ID: 31485674
[TBL] [Abstract][Full Text] [Related]
32. ARHGEF10L expression regulates cell proliferation and migration in gastric tumorigenesis.
Wang DW; Tang JY; Zhang GQ; Chang XT
Biosci Biotechnol Biochem; 2020 Jul; 84(7):1362-1372. PubMed ID: 32154766
[TBL] [Abstract][Full Text] [Related]
33. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.
Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH
Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312
[TBL] [Abstract][Full Text] [Related]
34. Identification of Rho GEF and RhoA Activation by Pull-Down Assays.
Sajib MS; Zahra FT; Akwii RG; Mikelis CM
Methods Mol Biol; 2021; 2193():97-109. PubMed ID: 32808262
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of Trio by CRISPR/Cas9 suppresses migration and invasion of cervical cancer cells.
Hou C; Zhuang Z; Deng X; Xu Y; Zhang P; Zhu L
Oncol Rep; 2018 Feb; 39(2):795-801. PubMed ID: 29207149
[TBL] [Abstract][Full Text] [Related]
36. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
37. Galpha13 regulation of proto-Dbl signaling.
Vanni C; Mancini P; Ottaviano C; Ognibene M; Parodi A; Merello E; Russo C; Varesio L; Zheng Y; Torrisi MR; Eva A
Cell Cycle; 2007 Aug; 6(16):2058-70. PubMed ID: 17721084
[TBL] [Abstract][Full Text] [Related]
38. Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA.
Takeshita A; Iwai S; Morita Y; Niki-Yonekawa A; Hamada M; Yura Y
Int J Oncol; 2014 Jan; 44(1):59-68. PubMed ID: 24220306
[TBL] [Abstract][Full Text] [Related]
39. ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.
Luo N; Guo J; Chen L; Yang W; Qu X; Cheng Z
Cell Death Dis; 2016 Mar; 7(3):e2157. PubMed ID: 27010858
[TBL] [Abstract][Full Text] [Related]
40. NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer.
Hu S; Meng F; Yin X; Cao C; Zhang G
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
